Posted by Social Science Research Network
Health Care Competition Law in the Shadow of State Action: Minimizing MACs
David A. Hyman (University of Illinois) & William E. Kovacic (George Washington University)
Abstract: How should we go about reconciling competition and consumer protection in health care, given the long shadow cast by the state action doctrine? We consider that issue, using a case study drawn from an obscure corner of the pharmaceutical reimbursement market to motivate and inform our analysis. We show how the balance between competition and consumer protection has been distorted by the political economy of health care regulation –compounded by the extension of the state action doctrine far past its defensible borders. If anything, considerations of political economy argue for much greater skepticism about the utility of regulation – and of the state action doctrine — in the health care space.
Featured News
    FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
    Jan 31, 2024 by
        CPI    
    UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
    Jan 31, 2024 by
        CPI    
    Greenberg Traurig Grow Financial Regulatory and Compliance Practice
    Jan 31, 2024 by
        CPI    
    Dutch Regulator Fines Uber €10 Million for Privacy Violations
    Jan 31, 2024 by
        CPI    
    DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
    Jan 31, 2024 by
        CPI    
Antitrust Mix by CPI
    Antitrust Chronicle® – The Rule(s) of Reason
    Jan 29, 2024 by
        CPI    
    Evolving the Rule of Reason for Legacy Business Conduct
    Jan 29, 2024 by
        CPI    
    The Object Identity
    Jan 29, 2024 by
        CPI    
    In Praise of Rules-Based Antitrust
    Jan 29, 2024 by
        CPI    
    The Future of State AG Antitrust Enforcement and Federal-State Cooperation
    Jan 29, 2024 by
        CPI